0 Комментарии
0 Поделились
219 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Комментарии 0 Поделились 116 Просмотры 0 предпросмотр
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 137 Просмотры 0 предпросмотр1
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Pirfenidone Tablets Market to Reach USD 2.08 Billion by 2034 Amid Rising IPF CasesAccording to a new report from Intel Market Research, the global Pirfenidone Tablets market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.08 billion by 2034, growing at a strong CAGR of 7.8% during the forecast period (2026–2034). This growth is driven by increasing prevalence of idiopathic pulmonary fibrosis (IPF), expanding geriatric population, and improved...0 Комментарии 0 Поделились 95 Просмотры 0 предпросмотр
-
Healthcare Education Solutions Market Graph: Growth, Share, Value, Size, and Insights"Regional Overview of Executive Summary Healthcare Education Solutions Market Market by Size and Share CAGR Value Global healthcare education solutions market size was valued at USD 10.30 billion in 2024 and is projected to reach USD 18.51 billion by 2032, with a CAGR of 7.60% during the forecast period of 2025 to 2032. Deliberately analyzed facts and figures of the market and keen...0 Комментарии 0 Поделились 29Кб Просмотры 0 предпросмотр
-
Intravenous Antiepileptic Drug Market Expected to Grow at 5.2% CAGR by 2034According to the latest analysis from Intel Market Research, the global Intravenous Antiepileptic Drug market was valued at USD 487 million in 2025 and is expected to reach USD 688 million by 2034, expanding at a steady CAGR of 5.2% during 2026-2034. This sustained growth reflects the critical need for rapid-onset seizure control in emergency neurological...0 Комментарии 0 Поделились 206 Просмотры 0 предпросмотр
-
Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer TherapiesThe rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр